IOL CHEMICALS & PHARM. | KILITCH DRUGS | IOL CHEMICALS & PHARM./ KILITCH DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.1 | 44.1 | 29.8% | View Chart |
P/BV | x | 1.5 | 3.9 | 38.7% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. KILITCH DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
KILITCH DRUGS Mar-23 |
IOL CHEMICALS & PHARM./ KILITCH DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 218 | 245.9% | |
Low | Rs | 272 | 121 | 224.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 89.6 | 421.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 5.3 | 445.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 7.6 | 415.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 93.9 | 273.6% | |
Shares outstanding (eoy) | m | 58.71 | 15.58 | 376.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.9 | 56.5% | |
Avg P/E ratio | x | 17.1 | 31.9 | 53.4% | |
P/CF ratio (eoy) | x | 12.8 | 22.4 | 57.3% | |
Price / Book Value ratio | x | 1.6 | 1.8 | 87.0% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 2,646 | 897.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 117 | 1,433.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,396 | 1,588.2% | |
Other income | Rs m | 256 | 29 | 877.7% | |
Total revenues | Rs m | 22,427 | 1,425 | 1,573.7% | |
Gross profit | Rs m | 2,257 | 177 | 1,272.8% | |
Depreciation | Rs m | 462 | 36 | 1,299.9% | |
Interest | Rs m | 165 | 51 | 324.0% | |
Profit before tax | Rs m | 1,887 | 120 | 1,570.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 37 | 1,326.6% | |
Profit after tax | Rs m | 1,391 | 83 | 1,679.8% | |
Gross profit margin | % | 10.2 | 12.7 | 80.1% | |
Effective tax rate | % | 26.2 | 31.1 | 84.5% | |
Net profit margin | % | 6.3 | 5.9 | 105.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,264 | 764.7% | |
Current liabilities | Rs m | 5,025 | 689 | 729.6% | |
Net working cap to sales | % | 20.9 | 41.2 | 50.8% | |
Current ratio | x | 1.9 | 1.8 | 104.8% | |
Inventory Days | Days | 43 | 163 | 26.5% | |
Debtors Days | Days | 8 | 1,419 | 0.6% | |
Net fixed assets | Rs m | 11,017 | 911 | 1,208.8% | |
Share capital | Rs m | 587 | 156 | 376.8% | |
"Free" reserves | Rs m | 14,490 | 1,307 | 1,109.0% | |
Net worth | Rs m | 15,077 | 1,462 | 1,031.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 2,175 | 950.8% | |
Interest coverage | x | 12.5 | 3.4 | 370.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.6 | 167.0% | |
Return on assets | % | 7.5 | 6.1 | 122.5% | |
Return on equity | % | 9.2 | 5.7 | 162.9% | |
Return on capital | % | 13.6 | 11.7 | 116.4% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 602 | 984.9% | |
Fx outflow | Rs m | 6,052 | 161 | 3,765.0% | |
Net fx | Rs m | -122 | 441 | -27.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 26 | 4,728.2% | |
From Investments | Rs m | -1,200 | 79 | -1,516.1% | |
From Financial Activity | Rs m | -41 | -7 | 574.0% | |
Net Cashflow | Rs m | -18 | 98 | -18.8% |
Indian Promoters | % | 48.2 | 69.2 | 69.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 30.8 | 168.4% | |
Shareholders | 130,003 | 9,525 | 1,364.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | KILITCH DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.36% | -0.04% | -0.62% |
1-Month | -4.68% | 1.07% | 1.98% |
1-Year | -4.26% | 112.79% | 49.56% |
3-Year CAGR | -12.06% | 53.05% | 14.14% |
5-Year CAGR | 15.31% | 11.27% | 19.15% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the KILITCH DRUGS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of KILITCH DRUGS the stake stands at 69.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of KILITCH DRUGS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
KILITCH DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of KILITCH DRUGS.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.